AU2095099A - Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparationand their use as muscarinic receptor (ant-)agonists - Google Patents
Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparationand their use as muscarinic receptor (ant-)agonistsInfo
- Publication number
- AU2095099A AU2095099A AU20950/99A AU2095099A AU2095099A AU 2095099 A AU2095099 A AU 2095099A AU 20950/99 A AU20950/99 A AU 20950/99A AU 2095099 A AU2095099 A AU 2095099A AU 2095099 A AU2095099 A AU 2095099A
- Authority
- AU
- Australia
- Prior art keywords
- preparationand
- phthalimide
- ant
- pyrrolidine
- agonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6862797P | 1997-12-23 | 1997-12-23 | |
US60068627 | 1997-12-23 | ||
PCT/US1998/027585 WO1999032479A1 (en) | 1997-12-23 | 1998-12-22 | Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparation and their use as muscarinic receptor (ant-)agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2095099A true AU2095099A (en) | 1999-07-12 |
Family
ID=22083741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU20950/99A Abandoned AU2095099A (en) | 1997-12-23 | 1998-12-22 | Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparationand their use as muscarinic receptor (ant-)agonists |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2095099A (en) |
WO (1) | WO1999032479A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003030892A1 (en) * | 2001-10-11 | 2003-04-17 | Alcon, Inc. | Methods for treating dry eye |
PL2516434T3 (en) | 2009-12-23 | 2015-11-30 | Takeda Pharmaceuticals Co | Fused heteroaromatic pyrrolidinones as syk inhibitors |
US9056873B2 (en) | 2011-06-22 | 2015-06-16 | Takeda Pharmaceutical Company Limited | Substituted 6-aza-isoindolin-1-one derivatives |
PL2780015T3 (en) | 2011-11-18 | 2017-06-30 | Heptares Therapeutics Limited | Muscarinic m1 receptor agonists |
SG11201501620QA (en) | 2012-09-18 | 2015-04-29 | Heptares Therapeutics Ltd | Bicyclic aza compounds as muscarinic m1 receptor agonists |
GB2519470A (en) * | 2013-09-18 | 2015-04-22 | Heptares Therapeutics Ltd | Bicyclic aza compounds as muscarinic M1 receptor agonists |
GB201404922D0 (en) | 2014-03-19 | 2014-04-30 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
GB201617454D0 (en) | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
WO2020205867A1 (en) | 2019-04-02 | 2020-10-08 | Aligos Therapeutics, Inc. | Compounds targeting prmt5 |
GB202020191D0 (en) | 2020-12-18 | 2021-02-03 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3316276A (en) * | 1965-10-06 | 1967-04-25 | Robins Co Inc A H | N-(3-pyrrolidinyl)-phthalimide derivatives |
GB1486104A (en) * | 1975-01-23 | 1977-09-21 | Wyeth John & Brother Ltd | Phthalimidopiperidine derivatives |
WO1996013262A1 (en) * | 1994-10-27 | 1996-05-09 | Merck & Co., Inc. | Muscarine antagonists |
WO1997016192A1 (en) * | 1995-10-31 | 1997-05-09 | Merck & Co., Inc. | Muscarine antagonists |
WO1997016186A1 (en) * | 1995-10-31 | 1997-05-09 | Merck & Co., Inc. | Muscarine agonists |
-
1998
- 1998-12-22 AU AU20950/99A patent/AU2095099A/en not_active Abandoned
- 1998-12-22 WO PCT/US1998/027585 patent/WO1999032479A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1999032479A1 (en) | 1999-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5203999A (en) | Beta3-adrenergic receptor agonists | |
AU5640299A (en) | 4-quinolinemethanol derivatives as purine receptor antagonists.(ii) | |
AU5640199A (en) | 4-quinolinemethanol derivatives as purine receptor antagonists (i) | |
HK1044952A1 (en) | N-pyrazole A2A receptor agonists n- A2A. | |
ZA200200298B (en) | C-Pyrazole A2A receptor agonists. | |
AU7692896A (en) | Quinazolin-2,4-diazirines as NPY receptor antagonist | |
AU2660399A (en) | Substituted quinoxaline derivatives as interleukin-8 receptor antagonists | |
AU3809999A (en) | Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes | |
AU4729699A (en) | Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists | |
AU2095099A (en) | Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparationand their use as muscarinic receptor (ant-)agonists | |
AU1948601A (en) | Triazospiro compounds having nociceptin receptor affinity | |
AU7132898A (en) | Edg-1-like receptor | |
AU4493496A (en) | Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht1d receptor agonists | |
AU3339697A (en) | Indoline derivatives useful as 5-ht-2c receptor antagonists | |
AU1073501A (en) | Histamine receptor | |
AU3550697A (en) | Aminocyclohexane derivatives as 5-ht receptor agonists | |
AU1296899A (en) | Phenyl-alkyl-imidazoles as h3 receptor antagonists | |
AU2001247227A1 (en) | 2-thioether a2a receptor agonists | |
AU2575399A (en) | Oxazole derivatives as serotonin-1a receptor agonists | |
AU4980999A (en) | A3 adenosine receptor antagonists | |
AU5861900A (en) | Receptor agonists and antagonists | |
AU8871898A (en) | Phenylindole derivatives as 5-ht2a receptor antagonists | |
AU3611099A (en) | Oxindole derivatives used as neurokinin receptor antagonists | |
AU6230698A (en) | Dopamine d4 receptor antagonist | |
AU3260297A (en) | Indoline derivatives useful as 5-ht-2c receptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |